Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Papi

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Recenti Progressi in Medicina|May 30, 2019
[The advantages of patient's active involvement in the management of chronic Inflammatory Bowel Diseases.]Giulia Zerboni, Stefano Festa, Annalisa Aratari, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 13, 2020
Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concernsStefano Festa, Annalisa Aratari, Fabiola De Biasio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 8, 2020
Acute kidney injury: an unexpected Isoniazid-related adverse event in a patient with Crohn's disease receiving prophylactic treatment for latent tuberculosisFabiola De Biasio, Annalisa Aratari, Sara Caporuscio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 28, 2023
Author's Reply: ``Use of biologics for the management of Crohn's disease''Stefanos Bonovas, Fabio Salvatore Macaluso, Daniele Piovani, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 11, 2013
Mucosal healing in inflammatory bowel disease: treatment efficacy and predictive factorsClaudio Papi, Federica Fascì-Spurio, Francesca Rogai, et al.
Expert Review of Gastroenterology & Hepatology|November 3, 2016
The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technologyCristina Bezzio, Federica Fascì-Spurio, Chiara Viganò, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 30, 2013
Low bioavailability and traditional systemic steroids in IBD: can the former take over the latter?Federica Fasci Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.
Recenti Progressi in Medicina|May 18, 2021
What are the challenges in selecting pharmacotherapy for pregnant women with inflammatory bowel disease?Annalisa Aratari, Giulia Zerboni, Fabiola De Biasio, et al.
Current Clinical Pharmacology|March 22, 2012
Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's diseaseFederica Fascì Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.
Digestive Diseases and Sciences|November 26, 2009
Oral beclomethasone dipropionate as an alternative to systemic steroids in mild to moderate ulcerative colitis not responding to aminosalicylatesClaudio Papi, Annalisa Aratari, Alessandra Moretti, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Recenti Progressi in Medicina|May 30, 2019
[The advantages of patient's active involvement in the management of chronic Inflammatory Bowel Diseases.]Giulia Zerboni, Stefano Festa, Annalisa Aratari, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 13, 2020
Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concernsStefano Festa, Annalisa Aratari, Fabiola De Biasio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 8, 2020
Acute kidney injury: an unexpected Isoniazid-related adverse event in a patient with Crohn's disease receiving prophylactic treatment for latent tuberculosisFabiola De Biasio, Annalisa Aratari, Sara Caporuscio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 28, 2023
Author's Reply: ``Use of biologics for the management of Crohn's disease''Stefanos Bonovas, Fabio Salvatore Macaluso, Daniele Piovani, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 11, 2013
Mucosal healing in inflammatory bowel disease: treatment efficacy and predictive factorsClaudio Papi, Federica Fascì-Spurio, Francesca Rogai, et al.
Expert Review of Gastroenterology & Hepatology|November 3, 2016
The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technologyCristina Bezzio, Federica Fascì-Spurio, Chiara Viganò, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 30, 2013
Low bioavailability and traditional systemic steroids in IBD: can the former take over the latter?Federica Fasci Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.
Recenti Progressi in Medicina|May 18, 2021
What are the challenges in selecting pharmacotherapy for pregnant women with inflammatory bowel disease?Annalisa Aratari, Giulia Zerboni, Fabiola De Biasio, et al.
Current Clinical Pharmacology|March 22, 2012
Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's diseaseFederica Fascì Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.
Digestive Diseases and Sciences|November 26, 2009
Oral beclomethasone dipropionate as an alternative to systemic steroids in mild to moderate ulcerative colitis not responding to aminosalicylatesClaudio Papi, Annalisa Aratari, Alessandra Moretti, et al.
Pageof 9